| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Revenue | $6.83B | -0.2% |
| Cost of Revenue | $3.37B | +7.7% |
| R&D Expense | $481.0M | +3.0% |
| SG&A Expense | $1.63B | -0.2% |
| Operating Income | $1.35B | -16.6% |
| Interest Expense | $95.0M | +13.1% |
| Pre-tax Income | $1.34B | -11.0% |
| Income Tax | $99.0M | -60.4% |
| Net Income | $1.24B |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.59B | +51.0% |
| Accounts Receivable | $1.29B | -8.1% |
| Inventory | $1.03B | -0.7% |
| Current Assets | $4.19B | +10.8% |
| Total Assets | $10.76B | +2.2% |
| Current Liabilities | $1.60B | -13.9% |
| Long-term Debt | $2.73B | +0.1% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.77B | +35.1% |
| Capital Expenditures | $298.0M | +2.4% |
| Investing Cash Flow | -$310.0M | +8.3% |
| Financing Cash Flow | -$930.0M | +32.2% |
| Free Cash Flow | $1.47B | +44.4% |
| -1.1% |
| EPS (Basic) | $4.22 | +0.7% |
| EPS (Diluted) | $4.19 | +0.2% |
| Total Liabilities |
| $4.92B |
| -5.9% |
| Stockholders' Equity | $5.84B | +10.2% |